Zdrowie i gospodarka · 14/07/2015

FDA Requests Public Comment on Proposed Clinical Investigations Oversight Guidance

The Food and Drug Administration (FDA) is seeking public input on a proposed rule that outlines a risk-based approach to monitoring clinical investigations, as required by the Paperwork Reduction Act of 1995.